You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪瑞醫療(300396.SZ):參股公司致善生物擬申請在全國中小企業股轉系統終止掛牌
格隆匯 10-09 19:40

格隆匯 10 月 9日丨迪瑞醫療(300396.SZ)公佈,公司參股公司廈門致善生物科技股份有限公司(以下簡稱“致善生物”)於2020年10月9日召開了其第三屆董事會第三次會議,審議通過了《關於申請公司股票在全國中小企業股份轉讓系統終止掛牌的議案》等相關議案,根據其業務發展及長期戰略發展規劃的需要,經其慎重考慮,致善生物擬申請其股票在全國中小企業股份轉讓系統終止掛牌。上述議案尚需提交致善生物2020年第四次臨時股東大會審議。

致善生物上述事項尚需其股東大會審議通過並報全國中小企業股份轉讓系統批准,其終止掛牌事宜尚存在不確定性。

迪瑞醫療目前持有致善生物15.6%的股份,本次致善生物股票擬終止在全國中小企業股份轉讓系統掛牌不會對迪瑞醫療的生產經營產生實質性影響,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account